Nurix bolsters leadership; plus Lynch named Xilio chairman, Edgewise, BioXCel, Catabasis, Catalyst and more

Nurix Therapeutics Inc. has announced a slew of leadership changes including Gwenn Hansen’s promotion to CSO from SVP of research, and Hans van Houte’s promotion to CFO from SVP of finance. The targeted protein degradation company, which raised $120 million in its fourth venture round in March,

Read the full 472 word article

How to gain access

Continue reading with a
two-week free trial.